Skip to content

Medline OGBCS23GT

by Medline Industries, Inc.

Medline OGBCS23GT is a Class II device made by Medline Industries, Inc., cleared under FDA 510(k) K151991 and listed in FDA GUDID since 7 May 2025 (UDI-DI 10197344112111), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K151991↗

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10197344112111 UDI-DI Date7 May 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberK151991 Date—StatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K151991 Active
  • FDA GUDID UDI-DI 10197344112111 listed 7 May 2025 Listed

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Medline
Generic name
Blood collection set, invasive
Model / Ref / Catalog
OGBCS23GT
Primary DI / UDI-DI
10197344112111
510(k) Number
FDA product code
FPA
GMDN term
Blood collection set, invasive
Device class
Class II
Regulation number
880.5440
GUDID distribution status
In Commercial Distribution
MRI safety
MR Unsafe

Related devices

Category: Blood collection set, invasive

Cleared under the same submission (K151991)

and 8 more cleared under K151991

Similar devices in this category

Other devices filed under Blood collection set, invasive.

Other devices from Medline Industries, Inc.

See all devices from Medline Industries, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (9, all answered No)